Twist Bioscience Corp Stock
Twist Bioscience Corp Stock
Twist Bioscience Corp dominated the market today, gaining €8.32 (27.860%).
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Twist Bioscience Corp.
As a result the target price of 41 € shows a slightly positive potential of 7.13% compared to the current price of 38.27 € for Twist Bioscience Corp.
Criterium "Revenue growth" is seen as the biggest plus for Twist Bioscience Corp stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Twist Bioscience Corp | 27.860% | 29.861% | 24.253% | 244.464% | 10.799% | -61.749% | - |
Gritstone Oncology Inc | 13.680% | 16.156% | -19.102% | -60.022% | -52.018% | -88.090% | - |
Avid Bioservices Inc | 0.700% | 5.109% | 24.138% | -55.556% | 18.033% | -60.000% | 78.174% |
Pacira Pharmaceuticals | 3.310% | 4.167% | -3.101% | -39.614% | -16.107% | -50.000% | -41.038% |
Comments
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Evercore ISI from $46.00 to $50.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Barclays PLC from $40.00 to $45.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Robert W. Baird from $39.00 to $40.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat